Bradford J. Shafer, EVP, General Counsel, Secretary at Theravance Biopharma, Inc. (TBPH), sold 62,600 shares at $28.99 ($1.7M) on 2018-08-07, disclosed to the SEC on 2018-08-09.
Seasonal sale ($1.7M) by EVP, General Counsel, Secretary — this insider has traded TBPH in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.03 | 4,127 | $116K | 6.6% |
| 2 | $28.03 | 4,127 | $116K | 6.6% |
| 3 | $28.99 | 1,818 | $53K | 3.0% |
| 4 | $28.99 | 1,818 | $53K | 3.0% |
| 5 | $27.85 | 25,355 | $706K | 40.4% |
| 6 | $27.85 | 25,355 |
| $706K |
| 40.4% |
| Total | $27.94 avg | 62,600 | $1.7M | 100% |
| Filing → |
| TBPH | SELL | 2017-09-08 | $903K | — | Filing → |
| TBPH | SELL | 2017-03-07 | $1.7M | — | Filing → |
| TBPH | SELL | 2016-08-22 | $1.3M | — | Filing → |